1. Federal Trade Commission. 2014a. GeneLink complaint. https://www.ftc.gov/system/files/documents/cases/140512genelinkcmpt.pdf. Accessed March 20, 2020.
2. ———. 2014b. Statement of Chairwoman Edith Ramirez and Commissioner Julie Brill. https://www.ftc.gov/sites/default/files/documents/cases/140107genelinkstatementbrill.pdf. .
3. Food and Drug Administration. 2018. FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. News release, March 6. https://www.fda.gov/news-events/press-announcements/fda-authorizes-special-controls-direct-consumer-test-reports-three-mutations-brca-breast-cancer. .
4. Golubeva, V.A., T. Nepomuceno, and A. Monteiro. 2019. Germline missense variants in BRCA1: New trends and challenges for clinical annotation. Cancers (Basel) 11(4): 522.
5. Harvard Health Publishing. 2010. Direct-to-consumer genetic testing kits. https://www.health.harvard.edu/newsletter_article/direct-to-consumer-genetic-testing-kits. Accessed March 16, 2020.